184 related articles for article (PubMed ID: 23604067)
1. A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.
Fontenot E; Rossi E; Mumper R; Snyder S; Siamakpour-Reihani S; Ma P; Hilliard E; Bone B; Ketelsen D; Santos C; Patterson C; Klauber-DeMore N
Mol Cancer Ther; 2013 May; 12(5):685-95. PubMed ID: 23604067
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
Garcia D; Nasarre P; Bonilla IV; Hilliard E; Peterson YK; Spruill L; Broome AM; Hill EG; Yustein JT; Mehrotra S; Klauber-DeMore N
Ann Surg Oncol; 2019 Dec; 26(13):4782-4790. PubMed ID: 31515721
[TBL] [Abstract][Full Text] [Related]
3. Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway.
Courtwright A; Siamakpour-Reihani S; Arbiser JL; Banet N; Hilliard E; Fried L; Livasy C; Ketelsen D; Nepal DB; Perou CM; Patterson C; Klauber-Demore N
Cancer Res; 2009 Jun; 69(11):4621-8. PubMed ID: 19458075
[TBL] [Abstract][Full Text] [Related]
4. The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.
Siamakpour-Reihani S; Caster J; Bandhu Nepal D; Courtwright A; Hilliard E; Usary J; Ketelsen D; Darr D; Shen XJ; Patterson C; Klauber-Demore N
PLoS One; 2011; 6(6):e20412. PubMed ID: 21673995
[TBL] [Abstract][Full Text] [Related]
5. Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis.
Peterson YK; Nasarre P; Bonilla IV; Hilliard E; Samples J; Morinelli TA; Hill EG; Klauber-DeMore N
Angiogenesis; 2017 Nov; 20(4):615-628. PubMed ID: 28840375
[TBL] [Abstract][Full Text] [Related]
6. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma.
Tsuruta JK; Klauber-DeMore N; Streeter J; Samples J; Patterson C; Mumper RJ; Ketelsen D; Dayton P
PLoS One; 2014; 9(1):e86642. PubMed ID: 24489757
[TBL] [Abstract][Full Text] [Related]
8. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
Wang X; Osada T; Wang Y; Yu L; Sakakura K; Katayama A; McCarthy JB; Brufsky A; Chivukula M; Khoury T; Hsu DS; Barry WT; Lyerly HK; Clay TM; Ferrone S
J Natl Cancer Inst; 2010 Oct; 102(19):1496-512. PubMed ID: 20852124
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling.
Wu Q; Yin X; Zhao W; Xu W; Chen L
PLoS One; 2021; 16(12):e0260864. PubMed ID: 34852024
[TBL] [Abstract][Full Text] [Related]
10. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
[TBL] [Abstract][Full Text] [Related]
11. Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma.
Tsuruta JK; Schaub NP; Rojas JD; Streeter J; Klauber-DeMore N; Dayton P
PLoS One; 2017; 12(3):e0174281. PubMed ID: 28333964
[TBL] [Abstract][Full Text] [Related]
12. Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells.
Xiao X; Xiao Y; Wen R; Zhang Y; Li X; Wang H; Huang J; Liu J; Long T; Tang J
Oncol Rep; 2015 Nov; 34(5):2259-66. PubMed ID: 26323494
[TBL] [Abstract][Full Text] [Related]
13. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
14. Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis.
van Loon K; Huijbers EJM; Griffioen AW
Cancer Metastasis Rev; 2021 Mar; 40(1):191-203. PubMed ID: 33140138
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
[TBL] [Abstract][Full Text] [Related]
16. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
19. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
[TBL] [Abstract][Full Text] [Related]
20. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
